Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
so much media deflection going on at present, when the hospital system is nearly broke and nobody is saying or doing fake all about it.....the staff shortages I'm seeing in the NHS are horrendous :-O
@JK,
all the more reason to enter a big contract with NCYT...the after care service has been superb with NCYT, business still maintained and growing.....just need to negotiate what payments are due & owed....this is common place with pretty much anyone who deals with the DHSC
I'd be crazy to sell before the two high potential seasons are right now ahead of NCYT.....almost like closing your toy shop before the Christmas season starts.....I also believe that within the next six months the DHSC will be resolved, DA will be bedded in selling product, Promate/ CO-Prep will be initiated into Project Ultraviolet Manchester and the USA footprint will be way under way....oh yes and the 2nd gen antibody will be sold into a vaccine developer/s ... ;-)
@ChrisT,
So since SP has no semblance on NCYTs real value, makes me think that the BoD are priming and gearing for future sale based on a future financial trigger point....it's what GM did with past companies and is/was doing with NCYT.....I hope that PIs don't lose theor bottle, have some balls and don't sell cheap....:-s
seeing that this thread is based on subjective hopeless thought and you being 'too emothionally involved and that's your downfall'....why self annihilate yourself and push the sentiment for an even lower SP of low £2s....don't make sense to me :-s
Hillseeker,
Think you got it right the first time :-)
I agree with your thoughts on shareholder comms and iis development....although the good RNS today has had negative affect on SP.....maybe the focus of the BoD is dealing with what they can influence, which is sales, product development, topline and growth ;-)
Ignore the ONS rates and see whats going on in UK hospitals right now.....and the peak hasn't even started yet. The need to test, diagnose and treat will be around for a very long time.....the knock on affect on hospital backlog grows by the day.
This is not about doom and gloom stories, it's about being invested at the right time and need....the day to day operations at NCYT is moving product to where it's needed right now.....not on a hope or a wishful whim like many AIMs out there
https://www.independent.co.uk/news/health/nhs-emergency-addenbrookes-wait-patients-b1927822.html
I did have this on another thread, but feel it does warrant some consideration or thought.....the current value on SP could bring on a takeover and take NCYT out of PLC....so the PIs need to buck up their sentiment outlook PDQ!...especially from some of the so called LTHs.....otherwise you'll be in more of a financial problem and in no control of the situation when the likes of e.g. the Kingfisher group and the likes start sniffing around..... the RNS, financials, product IPs and future potential is not driving the SP price...it's your sentiment!
yeah, I agree....unless desperate and in major need....it don't make sense.....just out of interest, if this was a Ltd company (non PLC) you were a partner of....would you be happy with the financials, product IPs and future potential?
a whiff of significant news (T/O, major long term contract etc) with the intitutions (iis etc) will suddenly put this back on the hit parade....it will propably come when most here have sold out anyway....IMO, the BoD doesn't take mush notice of the SP, but they very much look at the top line and longevity survival.....for me that's the right way round of priorities....today the news was good and still has a negative affect on the SP.....like the DHSC, the LFT delay it out of their hands, but CO-prep takes the priority with bigger margin potential anyways
for the home test, never in a million years will anyone compete with the far east LFT on price.....so a delay makes no odds, until the free tax payer one runs out....it's the private sector (Katalyst, Excalibur) where NCYT is well placed already for the LFT and much further ahead than the competition. Also the 2nd gen antibody LFT is the one to wait for, again for private sector vaccine developers.
In my experience in pharma, CO-Prep and even PROmate would have been developed under guidance from a big customer e.g. PROmate from my research would have been pushed by the DHSC to simplify the stages of prep work.....So, CO-Prep will also help simplify the process in another part of the testing protocol......to have state health usage is a massive endorsement around the world, especially with North America and Canada.
I'm hearing that only 1% of the quorum was reached from the 20% UK and 25% France....is that right?
That's a lot of votes to ask from the PIs, so for the AGM's resolutions to be reached the BoD will have to get the votes from somewhere, otherwise it's a stalemate situation.....I'm sure they'll want to go forward and ratify the AGM....they'll have to move on the motions to progress in some way.